Photodynamic Therapy in Ocular Oncology

Photodynamic Therapy in Ocular Oncology Publisher

Mazloumi M¹ ; Dalvin LA² ; Abtahi SH³ ; Yavari N⁴ ; Yaghy A¹ ; Mashayekhi A¹ ; Shields JA¹ ; Shields CL¹

Show Affiliations

1. Thomas Jefferson University, Wills Eye Hospital, Ocular Oncology Service, Philadelphia, United States
2. Department of Ophthalmology, Mayo Clinic, Rochester, United States
3. Isfahan Eye Research Center, Isfahan University of Medical Sciences, Feiz Hospital, Isfahan, Iran
4. Department of Cardiovascular Research, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Ophthalmic and Vision Research Published:2020

Abstract

Over the past two decades, we have witnessed the increasing use of photodynamic therapy (PDT) in the field of ocular oncology. Based on a review of the literature and our own experience, we herein review the role of PDT for the management of intraocular tumors. The discussion includes two main topics. First, we discuss the application of PDT for benign tumors, including circumscribed choroidal hemangioma, choroidal osteoma, retinal astrocytoma, retinal capillary hemangioma (retinal hemangioblastoma), and retinal vasoproliferative tumor. Second, we assess the role of PDT for malignant tumors, including choroidal melanoma and choroidal metastasis. © 2020 JOURNAL OF OPHTHALMIC AND VISION RESEARCH | PUBLISHED BY KNOWLEDGE E.

Related Docs

1. Intravitreal Bevacizumab for Management of Choroidal Osteoma Without Choroidal Neovascularization, Journal of Ophthalmic and Vision Research (2015)

2. Short-Term Effects of Photodynamic Therapy on Segmentation of Retinal Layers in Central Serous Chorioretinopathy, Advanced Biomedical Research (2021)

3. Baseline Subfoveal Choroidal Thickness As an Indicator for Bevacizumab Outcomes in Central Retinal Vein Occlusion, Tehran University Medical Journal (2019)

4. Photodynamic Therapy in Oral Cancer: A Narrative Review, Photobiomodulation, Photomedicine, and Laser Surgery (2023)

5. Ophthalmic Artery Occlusion Following Facial Sclerosing Therapy, Journal of Ophthalmic and Vision Research (2018)

Experts (# of related papers)

View all Related Experts

Alireza Dehghani (2)

Ali Salehi (1)

Style	Citing Format
MLA	Mazloumi M, et al.. "Photodynamic Therapy in Ocular Oncology." Journal of Ophthalmic and Vision Research, vol. 15, no. 4, 2020, pp. 547-558.
APA	Mazloumi M, Dalvin LA, Abtahi SH, Yavari N, Yaghy A, Mashayekhi A, Shields JA, Shields CL (2020). Photodynamic Therapy in Ocular Oncology. Journal of Ophthalmic and Vision Research, 15(4), 547-558.
Chicago	Mazloumi M, Dalvin LA, Abtahi SH, Yavari N, Yaghy A, Mashayekhi A, Shields JA, Shields CL. "Photodynamic Therapy in Ocular Oncology." Journal of Ophthalmic and Vision Research 15, no. 4 (2020): 547-558.
Harvard	Mazloumi M et al. (2020) 'Photodynamic Therapy in Ocular Oncology', Journal of Ophthalmic and Vision Research, 15(4), pp. 547-558.
Vancouver	Mazloumi M, Dalvin LA, Abtahi SH, Yavari N, Yaghy A, Mashayekhi A, et al.. Photodynamic Therapy in Ocular Oncology. Journal of Ophthalmic and Vision Research. 2020;15(4):547-558.
BibTex	@article{ author = {Mazloumi M and Dalvin LA and Abtahi SH and Yavari N and Yaghy A and Mashayekhi A and Shields JA and Shields CL}, title = {Photodynamic Therapy in Ocular Oncology}, journal = {Journal of Ophthalmic and Vision Research}, volume = {15}, number = {4}, pages = {547-558}, year = {2020} }
RIS	TY - JOUR AU - Mazloumi M AU - Dalvin LA AU - Abtahi SH AU - Yavari N AU - Yaghy A AU - Mashayekhi A AU - Shields JA AU - Shields CL TI - Photodynamic Therapy in Ocular Oncology JO - Journal of Ophthalmic and Vision Research VL - 15 IS - 4 SP - 547 EP - 558 PY - 2020 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract